<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugs_disease_country/PMC7467230/results/search/disease/results.xml">
  <result pre="drug use (IDU)-related infections such as human immunodeficiency virus (HIV)," exact="hepatitis" post="C virus (HCV), hepatitis B virus (HBV), and invasive"/>
  <result pre="such as human immunodeficiency virus (HIV), hepatitis C virus (HCV)," exact="hepatitis" post="B virus (HBV), and invasive bacterial and fungal infections,"/>
  <result pre="in injection opioids [5, 13] and hospitalizations for injection opioid-related" exact="endocarditis" post="have increased more than 12-fold in recent years [6,"/>
  <result pre="improve patients’ outcomes and reduce the public health risk of" exact="infectious disease" post="transmission. Nevertheless, a number of barriers to care in"/>
  <result pre="in the United States as well as reduce the other" exact="infectious disease" post="health outcomes. To address these barriers we recommend expanding"/>
  <result pre="[14, 15]; and buprenorphine and XR-NTX also improve HIV viral" exact="suppression" post="in people living with HIV, the gold standard of"/>
  <result pre="such as skin and soft tissue infections and risk of" exact="endocarditis" post="with a specific focus on criminal justice involved populations."/>
  <result pre="a specific focus on criminal justice involved populations. Abbreviations: HCV," exact="hepatitis" post="C virus; HIV, human immunodeficiency virus; IDU, injection drug"/>
  <result pre="34%, respectively [28]. SSPs also can facilitate vaccine uptake for" exact="hepatitis" post="A virus (HAV), HBV, influenza, and invasive pneumococcal disease,"/>
  <result pre="reduce progression to serious infections and reduce complications like wound" exact="botulism" post="or partial drainage of abscesses. Given the increased incidence"/>
  <result pre="either HIV or HCV who receive MOUDs have improved viral" exact="suppression" post="(HIV) [16, 17], achieve sustained virologic response/cure (HCV) [45,"/>
  <result pre="collaborative decisions on complex patients, such as those with recurrent" exact="endocarditis" post="following valve repair. Evaluation of the impact of these"/>
  <result pre="makes it difficult—if not impossible—to identify, predict, and prevent new" exact="infectious disease" post="epidemics related to substance use in the United States."/>
  <result pre="OUD leading to fatal overdose, progression of HIV, and HBV/HCV-induced" exact="liver disease" post="[66–68]. Additionally, overall infectious disease testing rates and rates"/>
  <result pre="progression of HIV, and HBV/HCV-induced liver disease [66–68]. Additionally, overall" exact="infectious disease" post="testing rates and rates of vaccination against HAV and"/>
  <result pre="against HAV and HBV are low [69, 70]. Integration of" exact="infectious disease" post="management with treatment for OUD in CJIP is an"/>
  <result pre="reducing these health inequities that will likely lead to improved" exact="infectious disease" post="outcomes and facilitates linkage to care postrelease [16, 17,"/>
  <result pre="decreases postrelease mortality [72, 73] and increases postrelease HIV viral" exact="suppression" post="[16, 17]. Clearly, prevention and treatment for OUD and"/>
  <result pre="also associated with suboptimal postrelease management of chronic conditions like" exact="liver disease" post="[82]. Increased flexibility of Medicaid, allowing initiation of insurance"/>
  <result pre="to IDU, such as skin and soft tissue infections or" exact="infective endocarditis." post="Despite increasing frequency of endocarditis in people with OUD/SUD"/>
  <result pre="soft tissue infections or infective endocarditis. Despite increasing frequency of" exact="endocarditis" post="in people with OUD/SUD [7], and high rates of"/>
  <result pre="HCV, and other IDU-related infections. As a result, we as" exact="infectious disease" post="specialists need a paradigm shift in our clinical approach,"/>
  <result pre="Wkly Rep2015; 64:443–4.25928470 5.ZibbellJE, AsherAK, PatelRC, et al.Increases in acute" exact="hepatitis" post="C virus infection related to a growing opioid epidemic"/>
  <result pre="Health2018; 108:175–81.29267061 6.SchranzAJ, FleischauerA, ChuVH, WuLT, RosenDLTrends in drug use-associated" exact="infective endocarditis" post="and heart valve surgery, 2007 to 2017: a study"/>
  <result pre="108:175–81.29267061 6.SchranzAJ, FleischauerA, ChuVH, WuLT, RosenDLTrends in drug use-associated infective" exact="endocarditis" post="and heart valve surgery, 2007 to 2017: a study"/>
  <result pre="Ann Intern Med2018; 170:31–40.30508432 7.WurcelAG, AndersonJE, ChuiKK, et al.Increasing infectious" exact="endocarditis" post="admissions among young people who inject drugs. Open Forum"/>
  <result pre="Open Forum Infect Dis2016; 3:ofw157.27800528 8.FleischauerAT, RuhlL, RheaS, BarnesEHospitalizations for" exact="endocarditis" post="and associated health care costs among persons with diagnosed"/>
  <result pre="Wkly Rep2017; 67:257–8. 13.HarrisAM, IqbalK, SchillieS, et al.Increases in acute" exact="hepatitis" post="B virus infections—Kentucky, Tennessee, and West Virginia, 2006–2013. MMWR"/>
  <result pre="on buprenorphine is associated with high levels of maximal viral" exact="suppression" post="among HIV-infected opioid dependent released prisoners. PLoS One2012; 7:e38335.22719814"/>
  <result pre="7:e38335.22719814 17.SpringerSA, Di PaolaA, AzarMM, et al.Extended-release naltrexone improves viral" exact="suppression" post="among incarcerated persons living with HIV with opioid use"/>
  <result pre="Integrating responses at the intersection of opioid use disorder and" exact="infectious disease" post="epidemics: proceedings of a workshop. Washington, DC: National Academies"/>
  <result pre="RioCintegrating treatment at the intersection of opioid use disorder and" exact="infectious disease" post="epidemics in medical settings: a call for action after"/>
  <result pre="and meta-analysis. Addiction2018; 113:545–63.28891267 29.PeakCM, StousSS, HealyJM, et al.Homelessness and" exact="hepatitis" post="A—San Diego County, 2016–2018 [published online ahead of print"/>
  <result pre="35.MacArthurGJ, van VelzenE, PalmateerN, et al.Interventions to prevent HIV and" exact="hepatitis" post="C in people who inject drugs: a review of"/>
  <result pre="in Affordable Care Act qualified health plans’ association with viral" exact="suppression" post="[published online ahead of print 18 November 2019]. Clin"/>
  <result pre="Dis2019; 68:1935–7.30357363 45.AkiyamaMJ, NortonBL, ArnstenJH, AgyemangL, HeoM, LitwinAHIntensive models of" exact="hepatitis" post="C care for people who inject drugs receiving opioid"/>
  <result pre="trial. Ann Intern Med2019; 170:594–603.30959528 46.AkiyamaM, LipseyD, MoonseongH, et al.Low" exact="hepatitis" post="reinfection following direct acting antiviral therapy among people who"/>
  <result pre="50.TalalAH, AndrewsP, McleodA, et al.Integrated, co-located, telemedicine-based treatment approaches for" exact="hepatitis" post="C virus management in opioid use disorder patients on"/>
  <result pre="women and infants prenatally exposed to substances, including infants with" exact="neonatal abstinence syndrome." post="MMWR Morb Mortal Wkly Rep2019; 68:777–83.31513558 52.collab: American College"/>
  <result pre="2019. 53.collab: US Preventive Services Task Force. Draft recommendation statement" exact="hepatitis" post="C virus infection in adolescents and adults: screening. Rockville,"/>
  <result pre="MD: USPSTF, 2019. 54.ZibbellJE, AsherAK, PatelRC, et al.Increases in acute" exact="hepatitis" post="C virus infection related to a growing opioid epidemic"/>
  <result pre="56.CottrellEB, ChouR, WassonN, RahmanB, GuiseJMReducing risk for mother-to-infant transmission of" exact="hepatitis" post="C virus: a systematic review for the U.S. Preventive"/>
  <result pre="38:1289–97. 59.BarocasJA, BeiserM, LeónC, GaetaJM, O’ConnellJJ, LinasBPExperience and outcomes of" exact="hepatitis" post="C treatment in a cohort of homeless and marginally"/>
  <result pre="2017. 63.HennesseyKA, KimAA, GriffinV, CollinsNT, WeinbaumCM, SabinKPrevalence of infection with" exact="hepatitis" post="B and C viruses and co-infection with HIV in"/>
  <result pre="and co-infection with HIV in three jails: a case for" exact="viral hepatitis" post="prevention in jails in the United States. J Urban"/>
  <result pre="co-infection with HIV in three jails: a case for viral" exact="hepatitis" post="prevention in jails in the United States. J Urban"/>
  <result pre="Public Health Rep2001; 116:203–9. 71.AkiyamaMJ, ColumbusD, MacDonaldR, et al.Linkage to" exact="hepatitis" post="C care after incarceration in jail: a prospective, single"/>
  <result pre="Infect Dis doi: 10.1093/cid/ciz383. 79.HeT, LiK, RobertsMS, et al.Prevention of" exact="hepatitis" post="C by screening and treatment in U.S. prisons. Ann"/>
  <result pre="BrockmannBW, VohrF, SpauldingA, MontagueBTA budget impact analysis of newly available" exact="hepatitis" post="C therapeutics and the financial burden on a state"/>
 </snippets>
</snippetsTree>
